AU3442200A - Genetic polymorphism and polymorphic pattern for assessing disease status, and compositions for use thereof - Google Patents

Genetic polymorphism and polymorphic pattern for assessing disease status, and compositions for use thereof

Info

Publication number
AU3442200A
AU3442200A AU34422/00A AU3442200A AU3442200A AU 3442200 A AU3442200 A AU 3442200A AU 34422/00 A AU34422/00 A AU 34422/00A AU 3442200 A AU3442200 A AU 3442200A AU 3442200 A AU3442200 A AU 3442200A
Authority
AU
Australia
Prior art keywords
compositions
genetic polymorphism
disease status
polymorphic pattern
assessing disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU34422/00A
Inventor
Lena Jonsson
Per Harry Rutger Lindstrom
Leif Torbjorn Norberg
Erik Olaisson
Rhiannon Sanders
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GEMINI GENOMICS AB
Original Assignee
GEMINI GENOMICS AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GEMINI GENOMICS AB filed Critical GEMINI GENOMICS AB
Publication of AU3442200A publication Critical patent/AU3442200A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU34422/00A 1999-03-23 2000-03-23 Genetic polymorphism and polymorphic pattern for assessing disease status, and compositions for use thereof Abandoned AU3442200A (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US12604699P 1999-03-23 1999-03-23
IB9900497 1999-03-23
WO900497 1999-03-23
US60126046 1999-03-23
US12624399P 1999-03-24 1999-03-24
US60126243 1999-03-24
US47189099A 1999-12-23 1999-12-23
US09471890 1999-12-23
PCT/GB2000/001102 WO2000056922A2 (en) 1999-03-23 2000-03-23 Genetic polymorphism and polymorphic pattern for assessing disease status, and compositions for use thereof

Publications (1)

Publication Number Publication Date
AU3442200A true AU3442200A (en) 2000-10-09

Family

ID=27383337

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34422/00A Abandoned AU3442200A (en) 1999-03-23 2000-03-23 Genetic polymorphism and polymorphic pattern for assessing disease status, and compositions for use thereof

Country Status (2)

Country Link
AU (1) AU3442200A (en)
WO (1) WO2000056922A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2733144C (en) 2003-12-17 2017-07-04 Fred Hutchinson Cancer Research Center Methods and materials for canine breed identification
WO2009113985A1 (en) * 2008-03-13 2009-09-17 Maria Athanasiou Genetic markers associated with response to antidepressants
US20100331673A1 (en) 2009-06-26 2010-12-30 Michael Maschke System and method for reducing patient risk of allergic reaction to contrast agents or medical material

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3465903B2 (en) * 1992-07-31 2003-11-10 ガーヴァン インスティチュート オブ メディカル リサーチ Assessing allelic variation in agonists
AUPN058895A0 (en) * 1995-01-16 1995-02-09 Garvan Institute Of Medical Research Diagnostic method
US6197505B1 (en) * 1997-04-04 2001-03-06 Pyrosequencing Ab Methods for assessing cardiovascular status and compositions for use thereof

Also Published As

Publication number Publication date
WO2000056922A2 (en) 2000-09-28
WO2000056922A3 (en) 2000-12-21

Similar Documents

Publication Publication Date Title
GB9904991D0 (en) Genetic screening
HUP0004880A2 (en) Novel nucleotid sequences coding for the zwa1 gene
AU3849999A (en) Endo-beta-n-acetylglucosaminidase gene
GB9809764D0 (en) MMP-9 Gene polymorphisms
AU1922801A (en) Genomic polymorphism for predicting therapeutic response
HUP0105208A3 (en) Gene therapy-1
AU3442200A (en) Genetic polymorphism and polymorphic pattern for assessing disease status, and compositions for use thereof
IL146332A0 (en) PrP-LIKE GENE
AU2003301874A8 (en) Asymmetric group 8 (viii) metallocene compounds
AU1466900A (en) Disease resistance factors
AU2002305788A1 (en) Genetic markers for improved disease resistance in animals (nramp1)
AU2002249453A1 (en) Enzyme and snp marker for disease
AU4692800A (en) Disease resistance factors
AU2002324711A1 (en) Single nucleotide polymorphisms diagnostic for schizophrenia
EP1215284A4 (en) Tsg-like gene
AU3269401A (en) Simultaneous hybridization/priming for snp analysis
AU7804300A (en) Modified resistance genes
EP1092021A4 (en) Npy-y7 receptor gene
AU1624601A (en) Human wnt gene
IL150084A0 (en) Compositions and methods for halogenation reactions
GB9907191D0 (en) Hydrotreating
GB9922281D0 (en) Polymorphism
AU2369100A (en) Plant disease resistance genes
GB0206993D0 (en) Susceptibility gene for inflammatory bowel disease
AU2002364883A1 (en) Means for identifying neisseiria menengitidis specific genes

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase